Sabina A Murphy Selected Research

BB-10153

8/2006

Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabina A Murphy Research Topics

Disease

192	Myocardial Infarction 12/2023 - 01/2002
113	Acute Coronary Syndrome 01/2023 - 01/2002
77	Stroke (Strokes) 12/2023 - 08/2004
76	Hemorrhage 01/2023 - 12/2002
65	ST Elevation Myocardial Infarction 01/2022 - 11/2002
41	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2002
38	Heart Failure 01/2023 - 06/2002
32	Unstable Angina 01/2023 - 07/2002
31	Ischemia 12/2023 - 01/2002
31	Atrial Fibrillation 11/2022 - 11/2013
31	Thrombosis (Thrombus) 01/2020 - 07/2002
24	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 11/2002
23	Ischemic Stroke 12/2023 - 04/2012
23	Atherosclerosis 12/2023 - 02/2003
23	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2018
20	Infarction (Infarctions) 01/2022 - 01/2002
19	Infections 01/2023 - 03/2006
16	Peripheral Arterial Disease 12/2023 - 08/2004
15	Coronary Disease (Coronary Heart Disease) 12/2023 - 02/2003
13	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 12/2005
13	Non-ST Elevated Myocardial Infarction 09/2009 - 01/2002
12	Diabetes Mellitus 12/2023 - 10/2002
11	Hypertension (High Blood Pressure) 01/2021 - 02/2003
9	Pathologic Constriction (Stenosis) 03/2024 - 12/2002
9	Embolism (Embolus) 01/2023 - 11/2013
8	Hemorrhagic Stroke 01/2023 - 08/2014
8	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 07/2002
8	Inflammation (Inflammations) 01/2016 - 02/2003
7	Body Weight (Weight, Body) 01/2022 - 05/2002
6	Transient Ischemic Attack 07/2016 - 10/2011
5	Neoplasms (Cancer) 01/2023 - 01/2018
4	Heart Diseases (Heart Disease) 01/2023 - 04/2007
4	Vascular Diseases (Vascular Disease) 01/2018 - 02/2007

Drug/Important Bio-Agent (IBA)

40	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 12/2005
39	Clopidogrel (Plavix)FDA Link 11/2022 - 08/2004
28	edoxabanIBA 01/2023 - 11/2013
27	Warfarin (Coumadin)FDA LinkGeneric 11/2022 - 11/2013
26	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
24	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 05/2002
22	dapagliflozinIBA 01/2023 - 01/2019
21	evolocumabIBA 12/2023 - 01/2017
21	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2002
21	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2005
21	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 05/2002
19	Atorvastatin (Lipitor)FDA Link 09/2015 - 07/2005
18	C-Reactive ProteinIBA 01/2020 - 04/2002
17	LDL CholesterolIBA 12/2023 - 12/2005
17	vorapaxarIBA 01/2020 - 04/2012
17	Pravastatin (Pravachol)FDA LinkGeneric 09/2015 - 12/2005
16	Troponin IIBA 01/2017 - 04/2002
16	Glycoproteins (Glycoprotein)IBA 07/2016 - 11/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 05/2002
15	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 05/2002
15	N(2)-(3-trifluoromethylphenyl)guanineIBA 02/2008 - 01/2002
14	omega-Chloroacetophenone (Mace)IBA 01/2023 - 06/2007
14	AnticoagulantsIBA 01/2019 - 04/2005
14	Neurofibromin 2 (Merlin)IBA 10/2015 - 04/2007
13	oxidized low density lipoproteinIBA 12/2023 - 12/2005
13	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 04/2002
13	Ranolazine FDA Link 08/2015 - 04/2007
12	LipidsIBA 12/2023 - 03/2005
12	TroponinIBA 01/2022 - 09/2003
12	Simvastatin (Zocor)FDA LinkGeneric 12/2017 - 12/2005
11	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2006
11	CreatinineIBA 01/2021 - 11/2003
11	Ezetimibe (Zetia)FDA Link 01/2020 - 09/2015
10	Eptifibatide (Integrilin)FDA Link 07/2007 - 05/2004
7	Proprotein Convertase 9IBA 12/2023 - 01/2018
7	SodiumIBA 01/2023 - 10/2007
7	Sodium-Glucose Transport ProteinsIBA 10/2022 - 01/2019
7	Thrombin Receptors (Thrombin Receptor)IBA 01/2017 - 12/2014
7	CalciumIBA 06/2009 - 02/2005
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2019
6	thienopyridineIBA 11/2015 - 11/2007
6	AntithrombinsIBA 09/2010 - 08/2004
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2009 - 10/2002
6	orbofibanIBA 05/2006 - 02/2003
5	HDL CholesterolIBA 04/2024 - 03/2010
5	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 04/2009
5	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 12/2018 - 02/2016
5	RivaroxabanIBA 10/2018 - 01/2012
5	MB Form Creatine KinaseIBA 10/2015 - 01/2002
5	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 09/2006 - 04/2002
5	Tenecteplase FDA Link 08/2004 - 04/2004
4	Triglycerides (Triacylglycerol)IBA 04/2024 - 02/2008
4	Dihydrotachysterol (AT 10)IBA 01/2022 - 07/2004
4	PAR-1 ReceptorIBA 04/2019 - 10/2012
4	TicagrelorIBA 01/2018 - 05/2015
4	Factor Xa InhibitorsIBA 01/2017 - 08/2014

Therapy/Procedure

122	Therapeutics 12/2023 - 01/2002
51	Percutaneous Coronary Intervention 03/2024 - 04/2002
23	Thrombolytic Therapy 09/2010 - 10/2002
21	Stents 03/2024 - 01/2002
18	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2024 - 07/2002
14	Secondary Prevention 01/2021 - 03/2005
14	Patient Readmission 07/2012 - 09/2002
6	Drug-Eluting Stents 03/2024 - 06/2003
6	Conservative Treatment 07/2008 - 07/2002
4	Surgical Amputation (Amputations) 01/2022 - 01/2018
4	Drug Tapering 07/2016 - 05/2007